Skip to main
BTSG

BTSG Stock Forecast & Price Target

BTSG Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 40%
Buy 60%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

BrightSpring Health is expected to continue performing well due to their strong competitive position, sustainable growth opportunities, recent acquisitions and investments, and shift towards serving Medicare patients. However, they face challenges in recruiting and retaining healthcare professionals and changes to Medicare and Medicaid rates could impact their revenue. Additionally, their reliance on pharmaceuticals and potential issues with drug price inflation and reduced participation in federal programs could also affect their business. Ultimately, their success depends on the reliability of their data systems and the financial stability of their clients.

Bears say

BrightSpring Health is facing pressure from Medicare in the home health sector and the Company is not immune to this, as evidenced by the recent reduction in cost per script. Additionally, competition is increasing in the post-acute provider care market and BrightSpring will need to focus on retaining market share. The Company has potential for long-term growth opportunities in its specialty pharmacy segment, but the home and community pharmacy business may face challenges that could impact overall financial performance in the future.

BTSG has been analyzed by 10 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 60% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of BrightSpring Health Services Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About BrightSpring Health Services Inc (BTSG) Forecast

Analysts have given BTSG a Buy based on their latest research and market trends.

According to 10 analysts, BTSG has a Buy consensus rating as of May 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $58, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $58, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

BrightSpring Health Services Inc (BTSG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.